title: Total Femur Replacement After Tumor Resection: Limb Salvage Usually Achieved But Complications and Failures are Common.
abstract: BACKGROUND
  Primary bone or soft tissue tumors of the femur sometimes present with severe and extensive bone destruction, leaving few limb-salvage options other than total femur replacement. However, there are few data available regarding total femur replacement and, in particular, regarding implant failures.
  
  
  OBJECTIVE
  We asked: (1) What are the revision-free and overall implant survival rates of conventional total femur replacements in patients treated for sarcoma of the femur or soft tissues? (2) What are the revision-free and overall implant survival rates of expandable total femur replacements in skeletally immature patients? (3) Using the comprehensive International Society of Limb Salvage failure-mode classification, what types of complications occur with conventional and expandable total femur replacements?
  
  
  METHODS
  Our retrospective, single-center cohort study was based on data prospectively collected for 50 patients who received a total femur replacement after tumor resection for indications other than carcinoma or metastatic disease. Of the 50 patients, six (12%) were lost to followup before 6 months. Ten of the remaining 44 patients received expandable implants. The mean followup was 57 months (range, 1-280 months) and 172 months (range, 43-289 months) for patients who underwent conventional and expandable total femur replacements, respectively. For implant survival, competing risk analyses were used.
  
  
  RESULTS
  At 5 years, revision-free implant survival of conventional total femur replacements was 48% (95% CI, 0.37-0.73), and overall implant survival was 97% (95% CI, 0.004-0.20). Five-year revision-free implant survival of expandable total femur replacements was 30% (95% CI, 0.47-1.00) and overall implant survival was 100%. With conventional total femur replacements soft tissue failures occurred in 13 of 34 patients, structural failures in three, infection in six, and local tumor progression in one. No patient had aseptic loosening with conventional total femur replacements, but hip disarticulation occurred in two patients owing to extensive wound-healing problems and infection. With expandable total femur replacements soft tissue failure, aseptic loosening, and infection occurred in one patient each of 10, and structural failures in three of 10 (two periprosthetic fractures, one loosening of an enhanced tendon anchor). No hip disarticulations were performed. Additionally expandable total femur replacement-related failures included hip instability in eight of 10 patients, contractures attributable to massive scar tissue in six, and defect of the implant's expansion mechanism in four patients.
  
  
  CONCLUSIONS
  Although the indications for total femoral resection are rare, we think that total femur replacement is a reasonable treatment option for reconstruction of massive femoral bone defects after tumor resection in adults and skeletally immature patients, and results in limb salvage in most patients.
  
  
  METHODS
  Level IV, therapeutic study.
authors.affiliation: Department of Orthopaedic Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria, florian.sevelda@meduniwien.ac.at.
authors.forename: Florian
authors.initials: F
authors.lastname: Sevelda
authors.forename: Reinhard
authors.initials: R
authors.lastname: Schuh
authors.forename: Jochen Gerhard
authors.initials: JG
authors.lastname: Hofstaetter
authors.forename: Martina
authors.initials: M
authors.lastname: Schinhan
authors.forename: Reinhard
authors.initials: R
authors.lastname: Windhager
authors.forename: Philipp Theodor
authors.initials: PT
authors.lastname: Funovics
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001317:Austria; D002648:Child; D002675:Child, Preschool; D018572:Disease-Free Survival; D005266:Femoral Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery*; D006801:Humans; D023821:Limb Salvage; D008297:Male; D008875:Middle Aged; D016348:Osseointegration; D010027:Osteotomy; D011474:Prosthesis Design; D011475:Prosthesis Failure; D019919:Prosthesis Implantation / Q000009:adverse effects / Q000295:instrumentation* / Q000379:methods; D011859:Radiography; D019651:Plastic Surgery Procedures / Q000009:adverse effects / Q000295:instrumentation* / Q000379:methods; D012086:Reoperation; D012189:Retrospective Studies; D012307:Risk Factors; D012509:Sarcoma / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery*; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult
references.citation: J Bone Joint Surg Br. 2002 Apr;84(3):401-6
references.pmid: 12002501
references.citation: Clin Orthop Relat Res. 2010 Nov;468(11):2860-6
references.pmid: 20680532
references.citation: Med J Malaysia. 2005 Jul;60 Suppl C:45-8
references.pmid: 16381283
references.citation: Acta Orthop Traumatol Turc. 2004;38(1):79-84
references.pmid: 15054304
references.citation: J Bone Joint Surg Am. 2011 Mar 2;93(5):418-29
references.pmid: 21368074
references.citation: Clin Orthop Relat Res. 2007 Apr;457:176-82
references.pmid: 17075378
references.citation: Eur J Surg Oncol. 2010 Apr;36(4):378-83
references.pmid: 20230929
references.citation: J Bone Joint Surg Br. 1995 Jul;77(4):608-14
references.pmid: 7615607
references.citation: Clin Orthop Relat Res. 1988 Apr;(229):143-8
references.pmid: 3349669
references.citation: Int Orthop. 2000;24(3):176-8
references.pmid: 10990394
references.citation: Clin Orthop Relat Res. 2005 Sep;438:60-4
references.pmid: 16131870
references.citation: Clin Orthop Relat Res. 1995 Jul;(316):195-206
references.pmid: 7634705
references.citation: Arch Orthop Trauma Surg. 2010 Feb;130(2):171-6
references.pmid: 19644695
references.citation: Compr Ther. 1977 Feb;3(2):13-9
references.pmid: 300049
references.citation: Clin Orthop Relat Res. 2000 Jun;(375):218-30
references.pmid: 10853173
references.citation: Bone Joint J. 2014 Nov;96-B(11):1436-40
references.pmid: 25371453
references.citation: Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):559-65
references.pmid: 17255278
references.citation: J Bone Joint Surg Br. 2009 Nov;91(11):1513-20
references.pmid: 19880899
references.citation: Int Orthop. 2009 Oct;33(5):1359-63
references.pmid: 19259671
references.citation: J Surg Oncol. 2011 Nov 1;104(6):561-5
references.pmid: 21695701
references.citation: Clin Orthop Relat Res. 1998 Dec;(357):157-70
references.pmid: 9917713
references.citation: Cancer. 1986 Feb 1;57(3):499-502
references.pmid: 3455838
references.citation: Indian J Orthop. 2012 Jul;46(4):470-4
references.pmid: 22912524
references.citation: Bull Hosp Joint Dis. 1965 Apr;26:21-34
references.pmid: 14333593
references.citation: J Bone Joint Surg Br. 2006 Jun;88(6):790-5
references.pmid: 16720775
references.citation: J Bone Joint Surg Br. 2012 Feb;94(2):265-9
references.pmid: 22323698
references.citation: Nature. 2000 Jul 13;406(6792):143-4
references.pmid: 10910342
references.citation: Clin Orthop Relat Res. 1993 Jan;(286):241-6
references.pmid: 8425352
references.citation: Int Orthop. 1994 Apr;18(2):90-5
references.pmid: 8039964
references.citation: Acta Orthop Scand. 1980 Oct;51(5):845-51
references.pmid: 6937103
references.citation: J Bone Joint Surg Am. 2012 Mar 21;94(6):537-47
references.pmid: 22438003